• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本免疫性 TTP 的 HLA 易感基因座:与不同 HLA-DR 结合的共享 ADAMTS13 肽的潜在作用

HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.

机构信息

Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan.

Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan.

出版信息

Blood. 2020 Jun 25;135(26):2413-2419. doi: 10.1182/blood.2020005395.

DOI:10.1182/blood.2020005395
PMID:
32253422
Abstract

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In white individuals, HLA allele DRB111 is a predisposing factor for iTTP, whereas DRB104 is a protective factor. However, the role of HLA in Asians is unclear. In this study, we analyzed 10 HLA loci using next-generation sequencing in 52 Japanese patients with iTTP, and the allele frequency in the iTTP group was compared with that in a Japanese control group. We identified the following HLA alleles as predisposing factors for iTTP in the Japanese population: DRB108:03 (odds ratio [OR], 3.06; corrected P [Pc] = .005), DRB3/4/5blank (OR, 2.3; Pc = .007), DQA101:03 (OR, 2.25; Pc = .006), and DQB106:01 (OR,: 2.41; Pc = .003). The estimated haplotype consisting of these 4 alleles was significantly more frequent in the iTTP group than in the control group (30.8% vs 6.0%; Pc < .001). DRB115:01 and DRB501:01 were weak protective factors for iTTP (OR, 0.23; Pc = .076; and OR, 0.23, Pc = .034, respectively). On the other hand, DRB111 and DRB104 were not associated with iTTP in the Japanese. These findings indicated that predisposing and protective factors for iTTP differ between Japanese and white individuals. HLA-DR molecules encoded by DRB108:03 and DRB111:01 have different peptide-binding motifs, but interestingly, bound to the shared ADAMTS13 peptide in an in silico prediction model.

摘要

免疫介导性血栓性血小板减少性紫癜(iTTP)是一种罕见的自身免疫性疾病,由中和抗 ADAMTS13 自身抗体引起。在白种人群中,HLA 等位基因 DRB111 是 iTTP 的易感因素,而 DRB104 是保护因素。然而,HLA 在亚洲人群中的作用尚不清楚。在这项研究中,我们使用下一代测序技术在 52 名日本 iTTP 患者中分析了 10 个 HLA 基因座,并比较了 iTTP 组和日本对照组的等位基因频率。我们发现以下 HLA 等位基因是日本人群中 iTTP 的易感因素:DRB108:03(比值比[OR],3.06;校正 P [Pc] =.005)、DRB3/4/5空白(OR,2.3;Pc =.007)、DQA101:03(OR,2.25;Pc =.006)和 DQB106:01(OR,2.41;Pc =.003)。这些等位基因组成的估计单倍型在 iTTP 组中的频率明显高于对照组(30.8%比 6.0%;Pc<.001)。DRB115:01 和 DRB501:01 是 iTTP 的弱保护因素(OR,0.23;Pc =.076;和 OR,0.23,Pc =.034,分别)。另一方面,DRB111 和 DRB104 与日本人的 iTTP 无关。这些发现表明,iTTP 在日本人和白种人之间存在不同的易感和保护因素。由 DRB108:03 和 DRB111:01 编码的 HLA-DR 分子具有不同的肽结合基序,但有趣的是,在一个基于计算机预测的模型中,它们与共享的 ADAMTS13 肽结合。

相似文献

1
HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.日本免疫性 TTP 的 HLA 易感基因座:与不同 HLA-DR 结合的共享 ADAMTS13 肽的潜在作用
Blood. 2020 Jun 25;135(26):2413-2419. doi: 10.1182/blood.2020005395.
2
Overlapping ADAMTS13 peptide binding profiles of DRB1∗08:03 and DRB1∗11:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura.DRB1∗08:03 和 DRB1∗11:01 重叠的 ADAMTS13 肽结合谱提示免疫介导的血栓性血小板减少性紫癜具有共同的发病机制。
J Thromb Haemost. 2023 Mar;21(3):616-628. doi: 10.1016/j.jtha.2022.09.002. Epub 2022 Dec 22.
3
Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.免疫性血栓性血小板减少性紫癜的新观点。
Front Immunol. 2021 Nov 11;12:757192. doi: 10.3389/fimmu.2021.757192. eCollection 2021.
4
[Immune-mediated thrombotic thrombocytopenic purpura and susceptible HLA alleles].[免疫介导的血栓性血小板减少性紫癜与易感的人类白细胞抗原等位基因]
Rinsho Ketsueki. 2022;63(4):277-285. doi: 10.11406/rinketsu.63.277.
5
Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.鉴定来自土耳其的免疫性血栓性血小板减少性紫癜患者相关的 HLA 等位基因。
Blood Coagul Fibrinolysis. 2024 Sep 1;35(6):307-315. doi: 10.1097/MBC.0000000000001318. Epub 2024 Jul 24.
6
The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura.人类白细胞抗原DRB1-DQB1单倍型在获得性特发性血栓性血小板减少性紫癜易感性中的作用。
Hum Immunol. 2017 Feb;78(2):80-87. doi: 10.1016/j.humimm.2016.11.005. Epub 2016 Nov 17.
7
The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura.人类白细胞抗原在特发性血栓性血小板减少性紫癜患者中作为易患和/或保护因素的作用。
Ann Hematol. 2012 Apr;91(4):507-10. doi: 10.1007/s00277-011-1384-z. Epub 2011 Dec 28.
8
HLA class II allele and haplotype frequencies in Koreans based on 107 families.基于107个家庭的韩国人HLA II类等位基因和单倍型频率
Tissue Antigens. 2002 Jun;59(6):475-86. doi: 10.1034/j.1399-0039.2002.590604.x.
9
Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.日本人群中自身免疫性多腺体综合征III型患者人类白细胞抗原DRB1、DQA1和DQB1的易感等位基因及单倍型
Horm Res. 2005;64(5):253-60. doi: 10.1159/000089293. Epub 2005 Oct 27.
10
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.质谱辅助鉴定 HLA-DR 和 HLA-DQ 上呈现的 ADAMTS13 衍生肽。
Haematologica. 2018 Jun;103(6):1083-1092. doi: 10.3324/haematol.2017.179119. Epub 2018 Mar 22.

引用本文的文献

1
VITT Pathophysiology: An Update.疫苗诱导的血栓性血小板减少症(VITT)的病理生理学:最新进展
Vaccines (Basel). 2025 Jun 17;13(6):650. doi: 10.3390/vaccines13060650.
2
The third form of thrombotic thrombocytopenic purpura shows up again: what is it, does it even exist, how to find out? Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura".血栓性血小板减少性紫癜的第三种形式再次出现:它是什么,是否真的存在,如何查明?对《无可检测的抗ADAMTS13抗体的获得性血栓性血小板减少性紫癜:一种可能的潜在自身免疫机制》及《血栓性血小板减少性紫癜的不同表现》的评论
Haematologica. 2025 Jun 1;110(6):1445-1448. doi: 10.3324/haematol.2025.287535. Epub 2025 Feb 27.
3
Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis-an amazing clue.先天性血栓性血小板减少性紫癜与人类白细胞抗原分析——一个惊人的线索。
Hematol Transfus Cell Ther. 2025 Jan-Mar;47(1):103746. doi: 10.1016/j.htct.2025.103746. Epub 2025 Feb 15.
4
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II.人类白细胞抗原基因座与疫苗诱导的免疫性血栓性血小板减少症的关联:血小板因子4衍生肽与MHC-II相互作用的潜在作用
Br J Haematol. 2025 Jan;206(1):290-295. doi: 10.1111/bjh.19838. Epub 2024 Oct 27.
5
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies.HLA-DR-DQ关联,结合血浆评分,是获得性血栓性血小板减少性紫癜(aTTP)的可靠预测指标,并有助于将aTTP与其他血栓性微血管病区分开来。
Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S170-S180. doi: 10.1016/j.htct.2023.11.016. Epub 2024 Feb 8.
6
Associations between HLA class II alleles and IgE sensitization to allergens in the Qatar Biobank cohort.卡塔尔生物样本库队列中HLA II类等位基因与过敏原IgE致敏之间的关联。
J Allergy Clin Immunol Glob. 2023 May 18;2(3):100117. doi: 10.1016/j.jacig.2023.100117. eCollection 2023 Aug.
7
Asian-type DEL (RHD*DEL1) with an allo-anti-D: A paradoxical observation in a healthy multiparous woman.亚洲型 DEL(RHD*DEL1)伴同种异体抗-D:健康多产妇中的一个矛盾观察。
Transfusion. 2023 Aug;63(8):1601-1611. doi: 10.1111/trf.17465. Epub 2023 Jul 19.
8
Immune and Hereditary Thrombotic Thrombocytopenic Purpura: Can ADAMTS13 Deficiency Alone Explain the Different Clinical Phenotypes?免疫性和遗传性血栓性血小板减少性紫癜:仅ADAMTS13缺乏就能解释不同的临床表型吗?
J Clin Med. 2023 Apr 25;12(9):3111. doi: 10.3390/jcm12093111.
9
The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review.极端年龄下血栓性血小板减少性紫癜的特点:一项叙述性综述
J Clin Med. 2023 Apr 23;12(9):3068. doi: 10.3390/jcm12093068.
10
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的病理生理学与管理前沿
Int J Hematol. 2023 Mar;117(3):331-340. doi: 10.1007/s12185-023-03552-8. Epub 2023 Feb 9.